Patent US4439357A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4439357A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for obtaining hepatitis-safe, sterile hemoglobin solutions free of pyrogens and stroma

Assignee: Biotest AG
•
Filing: 1982-07-30
•
Granted: 1984-03-27
•
Expires: 2002-07-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for obtaining hepatitis-safe, sterile, pyrogen- and stroma-free hemoglobin solutions of low potassium content comprising stirring an erythrocyte concentrate with about 1 to 6-times its volume of an about 5 to 15% aqueous solution of a sugar, sugar alcohol or high-molecular-weight colloid, adjusting the pH of the resulting suspension to about 5 to 6.5 with an acid which is physiologically tolerable as salt, allowing the erythrocytes to settle, removing the supernatant from the sediments, adjusting the pH of the sediment to about 7 to 8, homogenizing the sediment, adjusting its hematocrit to about 55 to 60%, treating the mass with a dilute beta-propiolactone solution, hemolyzing the residual solids and forming a suspension thereof, contacting the suspension with a cation exchanger in H + form until the pH has decreased to about 5 to 5.5 thereby to precipitate the stroma, separating from the liquid the cation exchanger and precipitated stroma, and adjusting the pH to about 7.2 to 7.6.

Inventors

  • 👤 Klaus Bonhard
  • 👤 Bertram Eichentopf
  • 👤 Norbert Kothe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 17:44
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/795; C07K14/805; A; A61; A61L; A61L2/00; A61L2/16; A61L2/18; A61K; A61K38/00; A61L2103/00; A61L2103/05; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 159 words
A process for obtaining hepatitis-safe, sterile, pyrogen- and stroma-free hemoglobin solutions of low potassium content comprising stirring an erythrocyte concentrate with about 1 to 6-times its volume of an about 5 to 15% aqueous solution of a sugar, sugar alcohol or high-molecular-weight colloid, adJusting the pH of the resulting suspension to about 5 to 6.5 with an acid which is physiologically tolerable as salt, allowing the erythrocytes to settle, removing the supernatant from the sediments, adjusting the pH of the sediment to about 7 to 8, homogenizing the sediment, adjusting its hematocrit to about 55 to 60%, treating the mass with a dilute beta-propiolactone solution, hemolyzing the residual solids and forming a suspension thereof, contacting the suspension with a cation exchanger in H + form until the pH has decreased to about 5 to 5.5 thereby to precipitate the stroma, separating from the liquid the cation exchanger and precipitated stroma, and adjusting the pH to about 7.2 to 7.6.
Claim 2
Dependent Claim 159 words
A process for obtaining hepatitis-safe, sterile, pyrogen- and stroma-free hemoglobin solutions of low potassium content comprising stirring an erythrocyte concentrate with about 1 to 6-times its volume of an about 5 to 15% aqueous solution of a sugar, sugar alcohol or high-molecular-weight colloid, adJusting the pH of the resulting suspension to about 5 to 6.5 with an acid which is physiologically tolerable as salt, allowing the erythrocytes to settle, removing the supernatant from the sediments, adjusting the pH of the sediment to about 7 to 8, homogenizing the sediment, adjusting its hematocrit to about 55 to 60%, treating the mass with a dilute beta-propiolactone solution, hemolyzing the residual solids and forming a suspension thereof, contacting the suspension with a cation exchanger in H + form until the pH has decreased to about 5 to 5.5 thereby to precipitate the stroma, separating from the liquid the cation exchanger and precipitated stroma, and adjusting the pH to about 7.2 to 7.6.
Claim 3
Dependent Claim 27 words
A process according to claim 1, wherein the temperature is from about 2° to 18° C. during the process up until at least the cation exchanger treatment.
Claim 4
Dependent Claim 24 words
A process according to claim 1, wherein the pH of the suspension is adjusted to about 5.4 prior to the settling of the erythrocytes.
Claim 5
Dependent Claim 21 words
A process according to claim 1, wherein the erythrocytes are allowed to settle for from about 15 minutes to 10 hours.
Claim 6
Dependent Claim 22 words
A process according to claim 1, wherein the pH of the sediment is adjusted to about 7.4 prior to the beta-propiolactone treatment.
Claim 7
Dependent Claim 53 words
A process according to claim 1, wherein one additional washing of the erythrocyte sediment with solution of sugar, sugar alcohol or colloid is performed before the beta-propiolactone treatment, and, after the beta-propiolactone treatment but before the cation exchanger treatment, the solids are washed three times with solution of sugar, sugar alcohol or colloid.
Claim 8
Dependent Claim 16 words
A process according to claim 6, including the further step of sterile filtering the final solution.

References Cited (Backward Citations)

US3864478A Cited
US4336248A Cited
US4001200A Cited
US4136093A Cited
US4376727A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-27 1987-09-26 1988-03-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-27 1991-09-26 1992-03-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-27 1995-09-26 1996-03-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag